| Tretinoin | Approved Investigational Nutraceutical | ELL2 | 22936 |
upregulated | Tretinoin results in increased expression of ELL2 mRNA | 5q15 | |
| Tretinoin | Approved Investigational Nutraceutical | ELMO1 | 9844 |
upregulated | Tretinoin results in increased expression of ELMO1 mRNA | 7p14.2-p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELMOD1 | 55531 |
upregulated | Tretinoin results in increased expression of ELMOD1 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ELMOD3 | 84173 |
upregulated | Tretinoin results in increased expression of ELMOD3 mRNA | 2p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ELN | 2006 |
downregulated | Tretinoin results in decreased expression of ELN mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ELOVL7 | 79993 |
upregulated | Tretinoin results in increased expression of ELOVL7 mRNA | 5q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELP4 | 26610 |
downregulated | Tretinoin results in decreased expression of ELP4 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | ELP4 | 26610 |
upregulated | Tretinoin results in increased expression of ELP4 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | EMC3 | 55831 |
upregulated | Tretinoin results in increased expression of EMC3 mRNA | 3p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EMC9 | 51016 |
downregulated | Tretinoin results in decreased expression of EMC9 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | EML1 | 2009 |
downregulated | Tretinoin results in decreased expression of EML1 mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EMP1 | 2012 |
upregulated | Tretinoin metabolite results in increased expression of EMP1 mRNA | 12p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EMP1 | 2012 |
upregulated | Tretinoin results in increased expression of EMP1 mRNA | 12p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EMP3 | 2014 |
upregulated | Tretinoin results in increased expression of EMP3 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ENAH | 55740 |
downregulated | Tretinoin results in decreased expression of ENAH mRNA | 1q42.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ENC1 | 8507 |
downregulated | Tretinoin results in decreased expression of ENC1 mRNA | 5q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ENC1 | 8507 |
upregulated | Tretinoin results in increased expression of ENC1 mRNA | 5q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ENO1 | 2023 |
downregulated | Tretinoin results in decreased expression of ENO1 mRNA | 1p36.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ENOSF1 | 55556 |
downregulated | Tretinoin results in decreased expression of ENOSF1 mRNA | 18p11.32 | |
| Tretinoin | Approved Investigational Nutraceutical | ENOSF1 | 55556 |
upregulated | Tretinoin results in increased expression of ENOSF1 mRNA | 18p11.32 | |
| Tretinoin | Approved Investigational Nutraceutical | ENPEP | 2028 |
upregulated | Tretinoin results in increased expression of ENPEP mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | ENPP5 | 59084 |
upregulated | Tretinoin results in increased expression of ENPP5 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ENY2 | 56943 |
downregulated | Tretinoin results in decreased expression of ENY2 mRNA | 8q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EP400NL | 347918 |
downregulated | Tretinoin results in decreased expression of EP400NL mRNA | 12q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | EPAS1 | 2034 |
upregulated | Tretinoin results in increased expression of EPAS1 mRNA | 2p21 | |